Young adults: Cocaine linked to intracerebral hemorrhage

A fifth of young adults whose blood vessels ruptured inside their brain abused drugs and more than 40 percent had malformed blood vessels.

The study included 307 patients with intracerebral hemorrhage ( ICH ).
Of the 75 patients 49-years-old or younger, 20 percent had drugs in their system.

" The dominant drug of abuse was cocaine, long recognized as a risk factor for intracerebral hemorrhage," said Michael Hoffmann, lead author of the study and at the University of South Florida ( USF ) - Tampa General Hospital. " Marijuana was another frequently abused drug and is beginning to emerge as a risk factor for stroke. Amphetamines also were commonly abused."

How these drugs make brain blood vessels prone to rupture is not clear, but is being studied, Hoffmann said.

The study analyzed the causes and outcomes of patients with intracerebral hemorrhage .
Twenty-four percent of ICH patients in a registry at Tampa General Hospital were ages 18 to 49. Half were women, about two thirds were Caucasian, 15 percent were black and 12 percent were Hispanic.

Intracerebral hemorrhage is often linked with high blood pressure in people over age 50, and in this study, 57 percent of those age 50 and older had it. Only 33 percent of ICH patients ages 18 to 49 had high blood pressure.

Of the younger patients in the study, 41 percent had malformed blood vessels, known as arteriovenous malformations, aneurysms or other vascular disorders.
Cerebral arteriovenous malformation occurs when blood vessels in the brain develop in an abnormal tangle in which the arteries connect directly to the veins without the normal capillaries between them.

The good news is that patients under age 50 who experience this vessel rupture inside the brain have better outcomes than older patients.

" Surprisingly, our study showed a low mortality rate compared to population studies," said Hoffmann, at USF.

The 30-day mortality was 14.6 percent for the younger group, significantly lower than for older patients, whose mortality rate was 21 percent, he said.
Previously, national population studies have found a high 30-day mortality rate for stroke patients with intracerebral hemorrhage. Some epidemiological data have suggested a 45 percent to 50 percent mortality rate, Hoffmann said.

Intracerebral hemorrhage has traditionally been associated with older age groups and higher mortality rates.

Hoffmann attributes the low mortality rate in younger ICH patients to intensive neurocritical care management at Tampa General. The protocol includes decreasing intracranial pressure and using drains to prevent hydrocephalus, mechanical ventilation, sepsis control, blood pressure control and cooling.

The younger patients came into the emergency room, then were rapidly transferred to a neurocritical care unit within six hours. Typically, patients are hospitalized in the neurocritical care unit for one to eight weeks. Patients were evaluated by MRI, CT and angiography.

" This new way of thinking about how to manage patients with intracerebral hemorrhage is an important approach, and patients are reaping benefits," Hoffmann said.

Most of the younger patients were able to live independently three to six months after their intracerebral hemorrhage, with only mild to moderate cognitive impairment that tends to improve over time, he said.

Source: University of South Florida Health, 2006



Altri articoli

The results from the phase III study known as GiACTA, which evaluated Tocilizumab ( Actemra, RoActemra ), an anti-IL-6 receptor...

Abdominal aortic aneurysm ( AAA ) repair aims to prevent premature death from AAA rupture. Elective repair is currently recommended...

Randomized controlled trials have shown no significant difference in survival between immediate open repair and surveillance with selective repair for...

Kawasaki disease ( KD ) is a severe childhood disease that many parents mistake for an inconsequential viral infection. If...

Individuals with two or more first-degree relatives who have had aneurysmal subarachnoid haemorrhage ( aSAH ) have an increased risk...

The Food and Drug Administration ( FDA ) has approved Valiant Captivia Thoracic Stent Graft System to be used in...

MHRA ( Medicines and Healthcare Products Regulatory Agency ) previously advised that the contraindications for Dabigatran ( Pradaxa ) had...

The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion recommending a change to...

Celgene has announced results of phase II trial ( BCT-001 ) on Apremilast, a oral targeted inhibitor of phosphodiesterase 4...

Cigarette smokers who were treated for cerebral aneurysms with coil embolization are at greater risk of developing another aneurysm. In...